10-Q: Graham Holdings Company Reports Strong First Quarter Results Driven by Education and Investments

Graham Holdings Company's first quarter 2024 results show a significant increase in net income, driven by gains in marketable equity securities and improved performance in education and healthcare.

Summary

• Graham Holdings Company reported a net income attributable to common shareholders of $124.4 million, or $27.72 per share, for the first quarter of 2024, a substantial increase compared to $52.3 million, or $10.88 per share, in the same period of 2023.
• The company's revenue for the first quarter of 2024 reached $1,152.7 million, a 12% increase from $1,031.5 million in the first quarter of 2023, with growth in education, healthcare, and automotive sectors.
• Operating income for the first quarter of 2024 was $35.4 million, up from $27.7 million in the first quarter of 2023, reflecting improvements in education, television broadcasting, and healthcare, and reduced losses in other businesses.
• The company experienced a significant gain of $104.2 million in net gains on marketable equity securities during the quarter.
• The education division saw a 12% revenue increase, reaching $422.6 million, with operating income rising to $30.6 million.
• Healthcare revenues increased by 26% to $128.2 million, driven by growth at CSI Pharmacy and home health services.
• Automotive revenues increased by 31% to $303.8 million, due to acquisitions and sales growth, but operating income declined due to lower gross margins on new and used vehicles.
• Manufacturing revenues decreased by 11% to $101.9 million, with operating income also declining due to lower demand and volumes.
• Other businesses saw a 9% revenue decline to $83.3 million, but operating results improved due to better performance at Slate.

Sentiment

Score: 8

Explanation: The document presents a strong financial performance with significant improvements in net income and revenue. The positive outlook and strategic investments suggest a positive trajectory for the company. However, some challenges in manufacturing and automotive sectors temper the overall sentiment.

Positives

• The company experienced a significant increase in net income and earnings per share.
• Revenue growth was strong across multiple divisions, particularly in education, healthcare, and automotive.
• Operating income improved due to better performance in key segments and reduced losses in other businesses.
• The company benefited from substantial gains in marketable equity securities.
• The education division showed strong growth, particularly in Kaplan International.
• Healthcare revenues increased significantly, driven by growth at CSI Pharmacy and home health services.
• The company's automotive business saw substantial revenue growth due to acquisitions and sales increases.

Negatives

• Manufacturing revenues and operating income declined due to lower demand and volumes.
• Automotive operating income decreased due to lower gross margins on new and used vehicles.
• Other businesses experienced a revenue decline, although operating results improved.
• Higher interest rates and debt balances led to increased net interest expense.
• The company recorded a non-operating loss of $0.4 million from the impairment of a cost method investment.
• The company recorded $0.4 million in expenses related to a Separation Incentive Program (SIP) at other businesses.

Risks

• The company is exposed to market risk due to its ownership of marketable equity securities, which are subject to equity price risk.
• Borrowing and cash-management activities are subject to interest rate risk.
• Foreign business operations are subject to foreign exchange rate risk.
• The company faces potential losses from legal, regulatory, and other proceedings.
• The company's automotive business is subject to fluctuations in gross margins on new and used vehicles.
• The manufacturing sector is experiencing lower demand and volumes, impacting revenue and operating income.
• The company's retransmission revenues are expected to decline due to cord-cutting trends.

Future Outlook

The company expects to fund its estimated capital needs primarily through existing cash balances and internally generated funds, and, as needed, from borrowings under its revolving credit facility. The company estimates that its capital expenditures will be in the range of $95 million to $105 million in 2024. The company expects to pay a dividend of $6.88 per share in 2024. Retransmission revenues are expected to decline compared with 2023, and this trend is expected to continue.

Management Comments

• Management believes that there are no existing claims or proceedings that are likely to have a material effect on the Company's business, financial condition, results of operations or cash flows.
• Management believes it is reasonably possible that future losses from existing and threatened legal, regulatory and other proceedings in excess of the amounts recorded could reach approximately $10 million.
• Management believes the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments necessary for a fair statement of the Company's financial position, results of operations, and cash flows as of and for the periods presented herein.
• Management believes it is reasonably possible that future losses from existing and threatened legal, regulatory and other proceedings in excess of the amounts recorded could reach approximately $10 million.
• In management's opinion, the Company will have sufficient financial resources to meet its business requirements in the next 12 months, including working capital requirements, capital expenditures, interest payments, potential acquisitions and strategic investments, dividends and stock repurchases.

Industry Context

The company's performance reflects broader trends in the education, healthcare, and automotive industries. The growth in education, particularly in international markets, aligns with the increasing demand for global education services. The healthcare sector's growth is consistent with the rising demand for home health and specialty pharmacy services. The automotive sector's performance is influenced by market conditions and consumer demand for new and used vehicles. The decline in manufacturing revenue reflects broader economic trends impacting industrial production.

Comparison to Industry Standards

• Graham Holdings' performance in the education sector, particularly Kaplan International, is comparable to other large education service providers with a focus on international markets, such as Pearson and EF Education First.
• The healthcare segment's growth, driven by CSI Pharmacy and home health services, is in line with trends seen in companies like LHC Group and Amedisys, which also focus on home-based healthcare solutions.
• The automotive segment's performance is comparable to other large dealership groups like AutoNation and Penske Automotive Group, which are also experiencing fluctuations in new and used vehicle margins.
• The manufacturing segment's decline is similar to trends seen in other industrial companies facing reduced demand and production volumes, such as those in the lumber and electrical components sectors.
• The company's investment portfolio performance is comparable to other diversified holding companies with significant equity holdings, such as Berkshire Hathaway and Markel, which also experience fluctuations based on market conditions.

Related Party Transactions

• The company's automotive subsidiary is managed by an entity affiliated with Christopher J. Ourisman, a member of the Ourisman Automotive Group family of dealerships.
• The company recorded $4.1 million and $3.5 million in revenue for services provided to the affiliates of GHG for the three months ended March 31, 2024 and 2023, respectively.
• The company recorded expense of $2.0 million and $1.7 million for operating and management services provided by Christopher J. Ourisman and his team of industry professionals for the three months ended March 31, 2024 and 2023, respectively.
• The Chief Executive Officer of Markel, Mr. Thomas S. Gayner, is a member of the Company's Board of Directors.

Stakeholder Impact

• Shareholders will benefit from the increased net income and earnings per share.
• Employees may see changes in benefits due to the pension plan amendments and elimination of 401(k) matching contributions.
• Customers of the education, healthcare, and automotive businesses may experience improved services and offerings.
• Suppliers may see changes in demand based on the performance of the manufacturing and other sectors.
• Creditors will be interested in the company's debt levels and ability to meet its obligations.

Next Steps

• The company plans to continue its cost reduction initiatives in the Leaf businesses, which are expected to be largely completed by the end of the second quarter of 2024.
• Framebridge plans to open additional stores in 2024, including an expansion into Texas.
• CRG plans to open new restaurants in Baltimore, MD; Washington, D.C.; and Reston, VA in mid 2024, late 2024 and late 2025, respectively.

Key Dates

Keywords

Graham Holdings, Education, Healthcare, Automotive, Manufacturing, Marketable Equity Securities, Kaplan, Television Broadcasting, Financial Results, Operating Income